investing

Analysts Jefferies upgraded Chemed (CHE) to Buy and raised target price to $620, expecting 22% upside

Jefferies has upgraded Chemed to a 'buy' rating and increased its price target to $620, indicating a potential 22% upside, following the company's strong third-quarter earnings that exceeded expectations. This upgrade reflects confidence in Chemed's recovery from recent operational challenges and its ability to regain a premium valuation.
Meta Platforms Amazon Exxon Mobil Coca-Cola Royal Caribbean Hormel Foods Chevron

Analysts Goldman Sachs highlight negative correlation between AI adoption and employment growth

Investors should pay attention to upcoming earnings reports from major companies like Hormel Foods, Coca-Cola, and Royal Caribbean, as they may provide insights into consumer behavior and economic trends. Additionally, concerns about rising interest rates and funding challenges for Big Tech could impact market dynamics.